Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease
Status:
Recruiting
Trial end date:
2021-12-25
Target enrollment:
Participant gender:
Summary
This trial is to investigate the safety and potential therapeutic efficacy of allogeneic
administration of umbilical cord-derived MSCs (UC-MSCs) as a supplementary intervention in
combination with standard COPD medication treatments in patients with moderate-to-severe COPD
based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019 and Vietnam
Ministry of Health's guidelines
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Vinmec Research Institute of Stem Cell and Gene Technology